About Altis Labs
Altis Labs is a Healthcare company based in Toronto (Canada) founded in 2018 by Felix Baldauf-Lenschen. Clinical imaging data is analyzed to predict treatment outcomes. Altis Labs has raised $31 million across 2 funding rounds from investors including Debiopharm, Richard Gliklich and Doug Foster. The company has 16 employees. Its chief executive, as recorded, is Felix Baldauf-Lenschen. Altis Labs offers products and services including IPRO. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is Altis Labs, Inc.
Company details
Altis Labs was founded in 2018 in Toronto, Canada, within the health technology sector. An online platform is operated to deliver insights from clinical imaging data using deep learning. Computed tomography, magnetic resonance imaging, and positron emission tomography scans are examined alongside patient history, records, demographics, and lab results. Treatment pathways and outcomes are predicted through this analysis.
- Headquarters Toronto, Canada
- Employees 16
- Founders Felix Baldauf-Lenschen
- SectorsHealthcare
- Email••••••••
- Website altislabs.com
- Social LinkedIn X
- Legal Name Altis Labs, Inc.
- Total Equity Funding$31M (USD)
in 2 rounds
- Latest Funding Round$25M (USD), Series A
Sep 2026
- InvestorsDebiopharm
& 4 more
- Employee Count16
Products & Services of Altis Labs
Altis Labs offers a comprehensive portfolio of products and services, including IPRO.
Predicts patient outcomes from CT scans for clinical research
Funding Insights of Altis Labs
Altis Labs has successfully raised a total of $31M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $25 million completed in September 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31M
- Total Rounds 2
- Last Round Series A — $25M
- First Round $6M
(Jun 2023)
- Investors Count 5
All 2 funding rounds of Altis Labs with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2026 | $25M | Series A | – | Orbimed, Qiming | – |
| Jun 2023 | $6M | Seed | – | Debiopharm |
5 investors in total: 3 institutional and 2 angel.
Investors in Altis Labs
Altis Labs has secured backing from 5 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Debiopharm, Richard Gliklich and Doug Foster.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| orbimed.com | ||||
| qimingvcusa.com | ||||
Biopharmaceutical company focused on oncology, infectious diseases, and orphan drugs | 1979 | debiopharm.com | Lausanne, Switzerland | |
RG Richard Gliklich | Angel investor, CEO of Element Biosciences, focused on biotech innovation | unknown_feab4483efae49d29 | ||
DF Doug Foster | Angel investor focusing on Indian startups, experienced in tech and innovation. | unknown_55c6bed77b574d208 |
Investor details for Altis Labs
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Altis Labs
10 people are tracked at Altis Labs (4 in leadership, 6 in team); the tracked headcount is 16.
| Name | Role | Group |
|---|---|---|
Felix Baldauf-Lenschen | Founder & CEO | Leadership |
John Riskas | Head of Artificial Intelligence | Leadership |
Duoaud Shah | Vice President of Clinical Partnerships | Leadership |
Helen Z. | Chief Of Staff | Leadership |
Howard Nguyen-Huu | Machine Learning Engineer | Team |
Vignesh Sivan | Machine Learning Engineer | Team |
Cameron Fordham | Finance And Operations Associate | Team |
Olufunso Aduayi | Radiology Annotator | Team |
Oleksandra Samorodova | Medical Imaging Team Lead | Team |
Matt Kramers | Lead Software Engineer | Team |
Complete people profiles for Altis Labs
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Altis Labs
3 dated milestones of Altis Labs across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Altis Labs is founded.
- Funding First funding round of $6.0M.
- Funding Latest funding round, Series A, of $25.0M.
Web traffic of Altis Labs
The website of Altis Labs (altislabs.com) receives about 4.6K visits a month.
- Monthly visits4.6K
▲ 16.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Altis Labs
Complete news archive for Altis Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Altis Labs
Altis Labs was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Altis Labs is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Felix Baldauf-Lenschen is the CEO of Altis Labs, as recorded in our data. They have also founded this company.
Altis Labs is a funded company, having raised a total of $31M across 2 funding rounds to date. The company's 1st funding round was a Seed of $6M, raised on Jun 2023.
Altis Labs has 16 employees.
Altis Labs was founded in 2018 in Toronto, Canada, within the health technology sector. An online platform is operated to deliver insights from clinical imaging data using deep learning. Computed tomography, magnetic resonance imaging, and positron emission tomography scans are examined alongside patient history, records, demographics, and lab results. Treatment pathways and outcomes are predicted through this analysis.
Altis Labs offers IPRO.
Altis Labs has 5 investors. Key investors include Debiopharm, Richard Gliklich, Doug Foster, Orbimed, and Qiming.
Altis Labs operates through Altis Labs, Inc..